| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10910931 | Lung Cancer | 2014 | 11 Pages | 
Abstract
												LATS2 expression level is predictive of survival in patients with resected lung AD. LATS2 may modulate and contribute to tumor growth via different signaling pathways in EGFR mutant and wild-type tumors.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Susan Y. Luo, Ko-Yung Sit, Alan D.L. Sihoe, Wai-Sing Suen, Wing-Kuk Au, Ximing Tang, Edmond S.K. Ma, Wai-Kong Chan, Ignacio I. Wistuba, John D. Minna, George S.W. Tsao, David C.L. Lam, 
											